| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2002;40:934.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Internal Medicine, Keio University School of Medicine (A.I., M.H., Y.K., Y.T., N.H., T. Saruta), Tokyo; and Nephrology Discovery Research Laboratory, Tanabe Seiyaku (T. Sugaya), Osaka, Japan.
Correspondence to Atsuhiro Ichihara, MD, Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. E-mail atzichi{at}sc.itc.keio.ac.jp
To define the role of angiotensin type 1A (AT1A) receptor in modulating tubuloglomerular feedback signals and to determine its relationship to neuronal NO synthase (nNOS), the diameter of the afferent arterioles of wild-type and AT1A receptordeficient mice was measured by the blood-perfused juxtamedullary nephron technique. The afferent arteriolar diameter of wild-type and AT1A receptordeficient mice averaged 16.7±0.6 (n=9) and 16.8±0.7 µm (n=9), respectively. In the wild-type mice, addition of 10 µmol/L acetazolamide to the blood perfusate exerted a biphasic afferent arteriolar constriction, with the initial response and sustained response averaging 47.2±3.8% and 33.9±3.3%, respectively. In AT1A receptordeficient mice, the initial response and sustained response averaged 51.6±3.6% and 9.5±1.3%, respectively, and the sustained response was significantly attenuated compared with that of wild-type mice. Inhibition of nNOS with 10 µmol/L S-methyl-L-thiocitrulline significantly decreased the afferent arteriolar diameter of AT1A receptordeficient mice, from 15.1±1.2 to 5.0±0.3 µm (n=7), and the decrease was significantly greater than that observed in wild-type mice (from 15.9±1.2 to 10.6±1.3 µm; n=8). During nNOS inhibition, the initial and sustained afferent arteriolar constrictor responses to acetazolamide in wild-type mice averaged 54.4±6.4% and 44.8±11.3%; respectively, and were similar to those in AT1A receptordeficient mice (53.2±6.4% and 59.5±4.4%, respectively). These results suggest that AT1A receptors enhance tubuloglomerular feedbackmediated afferent arteriolar constriction, at least in part, through reducing the counteracting modulation by nNOS.
Key Words: arterioles autoregulation mice nitric oxide synthase receptors, angiotensin II
This article has been cited by other articles:
![]() |
P. L. Diaz-Sylvester, M. C. Fiori, S. M. Dieguez, A. C. Muller, M. L. Lopardo, and C. E. Amorena Effect of chronic inhibition of converting enzyme on proximal tubule acidification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R2014 - R2020. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. C. Li, L. G. Navar, Y. Shao, and J. L. Zhuo Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient mice Am J Physiol Renal Physiol, August 1, 2007; 293(2): F586 - F593. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Park, B. J. Bivona, and L. M. Harrison-Bernard Compromised renal microvascular reactivity of angiotensin type 1 double null mice Am J Physiol Renal Physiol, July 1, 2007; 293(1): F60 - F67. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Harrison-Bernard, C. J. Monjure, and B. J. Bivona Efferent arterioles exclusively express the subtype 1A angiotensin receptor: functional insights from genetic mouse models Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1177 - F1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, M. Kihara, T. Hashimoto, K. Matsushita, Y.-I. Koide, K. Tamura, N. Hirawa, Y. Toya, A. Fukamizu, and S. Umemura Alterations in Renal Endothelial Nitric Oxide Synthase Expression by Salt Diet in Angiotensin Type-1a Receptor Gene Knockout Mice J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1756 - 1763. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kovacs, P. Komlosi, A. Fuson, J. Peti-Peterdi, L. Rosivall, and P. D. Bell Neuronal Nitric Oxide Synthase: Its Role and Regulation in Macula Densa Cells J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2475 - 2483. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |